ACELLYTRON THERAPEUTICS
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

ACELLYTRON THERAPEUTICS Trademark

Serial Number: 79415062 • Registration: 7895577

ACELLYTRON THERAPEUTICS is a trademark filed by Wuxi Biologics (Shanghai) Co., Ltd. on June 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Wuxi Biologics (Shanghai) Co., Ltd. (11 trademarks)

Building 2, No. 31 Yiwei Road,

Entity Type: 03

Trademark Details

Filing Date

June 3, 2024

Registration Date

August 19, 2025

Published for Opposition

June 3, 2025

Goods & Services

Preparation of prescriptions by pharmacists; stem cell therapy services; medical clinic services; providing medical information; DNA screening for medical purposes; medical analysis services for the diagnosis of cancer; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical screening; health care; medical assistance

Chemical-pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; biochemical medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; vaccine preparations; influenza vaccine; chemotherapeutics; stem cells for medical purposes; medicines for human purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for medical purposes, namely, medicines for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer; drugs for treatment of cancer; medical preparation for treating diseases and disorders related to the immune system; biological agent, namely, biological preparations for treating cancer; pharmaceutical preparations for the prevention and treatment of cancer; living cells for medical use; medical cell inhibitor for inhibiting the growth of cancer cells; reagents for medical purposes; anticancer agent; diagnostic reagents for medical purposes; pharmaceutical preparations, namely, tumor suppressors; cells for medical use; dietetic infusions, sugar, foods, and beverage substances adapted for medical use; biological preparations for veterinary purposes for the treatment of autoimmune, neurodegenerative, metabolic, viral and infectious diseases, for the treatment of cancer

Online advertising on a computer network; advertising services; publicity agents; dissemination of advertising and advertising matter in the nature of flyers, prospectuses, brochures, leaflets and samples; providing commercial information and advice for consumers in the choice of products and services; organization of exhibitions and trade fairs for commercial or advertising purposes; import-export agency services; marketing services; sponsorship search; retail store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies

Research and development of new products for others; technological research in the field of chemical and biological medicaments; chemical analysis; biochemical research and analysis; research and development in the field of pharmaceutical preparations; medical research service; research and development services in the field of antibodies; stem cell research services; medical research; medical and scientific research, namely, conducting clinical trials for others; biological research; computer programming in the field of medical aspects

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 9, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 22, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 22, 2026 OPNR
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 26, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 5, 2026 FICS
FINAL DISPOSITION PROCESSED
Mar 5, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 20, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 19, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 19, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 5, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
May 5, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 5, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
May 5, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 5, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 23, 2025 TROA
REFUSAL PROCESSED BY IB
Mar 29, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 3, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 2, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 29, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 29, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 23, 2025 REPR